On the contrary, in two recently published cross-sectional studies of consecutive Polish CRC patients, the prevalence of RCC was 14.7% [22] or 11.9% [23] in the subgroup without the RAS and BRAF mutations, which is similar to the value reported in this study. Here, BRAF is linked to colorectal carcinoma.